Literature DB >> 23475156

[Treatment of diarrhea with loperamide in palliative medicine. A systematic review].

T Pastrana1, W Meißner.   

Abstract

Diarrhea is a distressing symptom which limits the quality of life in patients receiving palliative care and is associated with high morbidity and mortality. In patients with AIDS, it is a more common problem than for other entities (e.g., cancer). Loperamide is considered the first choice medication for the symptomatic treatment of diarrhea. This literature review examines the efficacy of loperamide in the symptomatic treatment of diarrhea in palliative care. Two databases (Medline and Embase) were searched through June 2012. A total of 286 studies were identified, but only 7 met the inclusion criteria (1 cohort and 6 experimental studies) in which loperamide (alone or in combination) was tested. There is a lack of significant studies which investigate the efficacy of loperamide in the symptomatic treatment of diarrhea. Two trials indicated superiority of loperamide over placebo. In comparison with octreotide, the results were contradictory. The combination of acetorphan with loperamide was more effective than acetorphan alone, but the combination of loperamide with diphenoxylate was inferior to octreotide. The identified studies revealed methodical problems. A definite recommendation for administration of loperamide can, therefore, not be derived from this work.The English full-text version of this article is available at SpringerLink (under "Supplemental").

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475156     DOI: 10.1007/s00482-013-1296-z

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  21 in total

1.  [The PRISMA Statement - what should be reported about systematic reviews?].

Authors:  Gerd Antes; E von Elm
Journal:  Dtsch Med Wochenschr       Date:  2009-07-31       Impact factor: 0.628

Review 2.  [Methods and development of therapy recommendations for symptom control in palliative medicine].

Authors:  L Radbruch; B Alt-Epping; R Rolke; M Ujeyl; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 3.  What palliative care-related problems do patients experience at HIV diagnosis? A systematic review of the evidence.

Authors:  Victoria M Simms; Irene J Higginson; Richard Harding
Journal:  J Pain Symptom Manage       Date:  2011-05-26       Impact factor: 3.612

4.  Gastrointestinal function in chronic radiation enteritis--effects of loperamide-N-oxide.

Authors:  E K Yeoh; M Horowitz; A Russo; T Muecke; T Robb; B E Chatterton
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 5.  Evidence behind the WHO guidelines: Hospital Care for Children: what is the aetiology and treatment of chronic diarrhoea in children with HIV?

Authors:  Alasdair Ford; Trevor Duke; Harry Campbell
Journal:  J Trop Pediatr       Date:  2009-12       Impact factor: 1.165

6.  Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors:  Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

Review 7.  [Chemotherapy-induced diarrhea].

Authors:  Kunihiko Kobayashi
Journal:  Gan To Kagaku Ryoho       Date:  2003-06

Review 8.  Diarrhea in terminally ill patients: pathophysiology and treatment.

Authors:  S Mercadante
Journal:  J Pain Symptom Manage       Date:  1995-05       Impact factor: 3.612

Review 9.  Review: loperamide--a potent antidiarrhoeal drug with actions along the alimentary tract.

Authors:  H Ruppin
Journal:  Aliment Pharmacol Ther       Date:  1987-06       Impact factor: 8.171

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  1 in total

1.  Identification of Potential Parkinson's Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network.

Authors:  Jie Liu; Dongdong Peng; Jinlong Li; Zong Dai; Xiaoyong Zou; Zhanchao Li
Journal:  Molecules       Date:  2022-07-26       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.